Imaging correlates of molecular signatures in oligodendrogliomas

Clinical Cancer Research

Volumn 10, Issue 13, 2004, Pages 4303-4306

  Megyesi, Joseph F ^a   Kachur, Edward ^a   Lee, Donald H ^a   Zlatescu, Magdalena C ^c   Betensky, Rebecca A ^b   Forsyth, Peter A ^c   Okada, Yoshifumi ^d   Sasaki, Hikaru ^d   Mizoguchi, Masahiro ^d   Louis, David N ^d   Cairncross, J Gregory ^c,e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; AGED; ALLELE; ARTICLE; CALCIFICATION; CANCER GROWTH; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GENOTYPE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BRAIN; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION;

EID: 3042851659     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0209     Document Type: Article

References (20)

1. Cairncross JG, Macdonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988;23:360-4.
2. Macdonald DR, Gaspar LE, Cairncross JG. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 1990; 27:573-4.
3. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst (Bethesda) 1998;90:1473-9.
4. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000;18:636-45.
5. Thiessen B, Maguire JA, McNeil K, Huntsman D, Martin MA, Horsman D. Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity. J Neurooncol 2003;64:271-8.
6. Chahlavi A, Kanner A, Peereboom D, Staugaitis SM, Elson P, Barnett G. Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results. J Neurooncol 2003;61: 267-73.
7. Ino Y, Betensky RA, Zlatescu MC, et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 2001;7:839-45.
8. Bauman GS, Ino Y, Ueki K, et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 2000;43:825-30.
9. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994; 145:1175-90.
10. Henkelman RM, Watts JF, Kucharczyk W. High signal intensity in MR images of calcified brain tissue. Radiology 1991;179:199-206.
11. Kim JK, Kucharczyk W, Henkelman RM. Cavernous hemangiomas: dipolar susceptibility artefacts at MR imaging. Radiology 1993; 187:735-41.
12. Louis DN, von Deimling A, Seizinger BR. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 1992;141:777-82.
13. Westfall PH, Young SS. On adjusting p-values for multiplicity. Biometric 1993;49:941-4.
14. Zlatescu MC, TehraniYazdi A-R, Sasaki H, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 2001;61:6713-5.
15. Mukasa A, Ueki K, Matsumoto S, et al. Distinction in gene expression profiles in oligodendrogliomas with and without allelic loss of 1p. Oncogene 2002;21:3961-8.
16. Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003;62:111-26.
17. van den Bent MJ, Looijenga LHJ, Langenberg K, et al. Chromosomal anomalies in oligodendroglial tumors are correlated to clinical features. Cancer (Phila) 2003;97:1276-84.
18. Burton EC, Lamborn KR, Feuerstein BG, et al. Genetic alterations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 2002;62:6205-10.
19. Mitchell JR, Jones C, Karlik SJ, et al. MR multispectral analysis of multiple sclerosis lesions. J Magn Reson Imaging 1997;7:499-511.
20. Preul MC, Caramanos Z, Collins DL, et al. Accurate, non-invasive diagnosis of human brain tumors by using magnetic resonance spectroscopy. Nat Med 1996;2:323-5.